Biocon promoter group declares no encumbrance on shares in FY26

1 min read     Updated on 16 Jun 2026, 12:43 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Biocon Limited's promoter group and Persons Acting in Concert have declared that no shares held by them were encumbered directly or indirectly during the financial year ending March 31, 2026. The declaration was submitted in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This confirmation was communicated to the BSE and National Stock Exchange of India.

powered bylight_fuzz_icon
43096409

*this image is generated using AI for illustrative purposes only.

Biocon Limited's promoter group and Persons Acting in Concert (PAC) have confirmed that no shares held by them in the company were encumbered during the financial year ending March 31, 2026. The declaration ensures that the promoters have not pledged their shares as collateral for loans or other obligations, providing stability regarding the company's ownership structure.

The confirmation was submitted by Ms. Kiran Mazumdar Shaw on behalf of the promoter and promoter group. The disclosure was made in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulatory requirement mandates promoters to disclose any encumbrance on their holdings to ensure transparency for shareholders.

The declaration was addressed to the stock exchanges, including BSE Limited and the National Stock Exchange of India Limited, as well as the Chairperson of the Audit Committee of Biocon Limited . The document confirms that the status of 'no encumbrance' was maintained throughout the specified financial year.

Key Details of the Declaration

Detail Description
Regulation Regulation 31(4) of SEBI SAST Regulations, 2011
Financial Year Year ending March 31, 2026
Encumbrance Status None
Entities Covered Promoter, Promoter Group, and Persons Acting in Concert

The filing confirms that the promoter group's shareholding remains free from liens or charges. This disclosure is critical for investors as it indicates that the promoters' stakes are not at risk of being sold off by lenders in the event of a default, which could otherwise lead to a sudden change in ownership or a drop in share price.

Historical Stock Returns for Biocon

1 Day5 Days1 Month6 Months1 Year5 Years
-0.14%-0.73%-1.89%+7.70%+15.20%+2.82%

How will this clean ownership structure influence Biocon's ability to raise capital for future expansion?

What impact will this declaration have on investor confidence and stock volatility in the upcoming quarter?

Could this signal a shift in Biocon's strategy towards more aggressive mergers and acquisitions?

Biocon Invests ₹5.48 Crore in Ampin Solar Power SPV to Boost Green Energy Use

1 min read     Updated on 11 Jun 2026, 05:40 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Biocon Limited has invested ₹5,47,60,000 in Ampin C&I Power Twelve Private Limited, a solar power SPV, acquiring 54,76,000 equity shares at ₹10 each, representing a 37.77% undiluted stake expected to reduce to 15.91% on full dilution. AMPIN is setting up a 27.12 MW (DC) solar plant in Karnataka, supporting Biocon's decarbonization goals and captive power requirements under the Electricity Act.

powered bylight_fuzz_icon
42648987

*this image is generated using AI for illustrative purposes only.

Biocon Limited has acquired an equity stake in Ampin C&I Power Twelve Private Limited (AMPIN) to enhance renewable energy consumption and reduce operational costs. The company invested ₹5,47,60,000 towards the subscription of 54,76,000 equity shares at a face value of ₹10 each. This strategic move supports Biocon's decarbonization goals and ensures a captive power status as per the Electricity Act.

The acquisition was disclosed to the stock exchanges on June 10, 2026, under Regulation 30 of the SEBI Listing Regulations. AMPIN, incorporated on April 23, 2025, is a Special Purpose Vehicle formed for the generation and supply of solar power. The entity reported a net worth of ₹120.78 million as on March 31, 2026, with a standalone turnover of nil and a loss after tax of ₹1.28 million for FY 2025-26.

Investment Details

The transaction was executed via cash consideration. Following the investment, Biocon holds 59,76,000 equity shares, representing 37.77% of AMPIN's paid-up share capital on an undiluted basis. However, this percentage is expected to reduce to 15.91% on a fully diluted basis after proposed investments by other entities in AMPIN. The key parameters of the investment are outlined below:

Particulars: Details
Investment Amount: ₹5,47,60,000
Shares Acquired: 54,76,000 equity shares
Face Value: ₹10 each
Current Stake: 37.77% (undiluted)
Post-dilution Stake: 15.91% (fully diluted)

Operational Objectives

AMPIN is engaged in the business of renewable energy generation and is setting up a Solar Power Plant with a capacity of 27.12 MW (DC) in Karnataka. The acquisition is not a related party transaction, and Biocon's promoters have no interest in the target entity. The agreements between Biocon and AMPIN include a Power Purchase Agreement and a Share Purchase, Subscription, and Shareholders Agreement to maintain the captive status required for regulatory compliance.

Historical Stock Returns for Biocon

1 Day5 Days1 Month6 Months1 Year5 Years
-0.14%-0.73%-1.89%+7.70%+15.20%+2.82%

How will the dilution of Biocon's stake to 15.91% impact its ability to maintain captive power status under the Electricity Act?

What is the projected timeline for the commissioning of the 27.12 MW solar power plant in Karnataka?

How significant will the operational cost savings be relative to Biocon's total energy expenditure?

More News on Biocon

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:+15.20%